H.C. Wainwright Reiterates Buy Rating on SpyGlass Pharma (SGP) Oct 21, 2026 06:49AM
SpyGlass Pharma reports 4-year glaucoma implant trial data Oct 19, 2026 08:04AM
H.C. Wainwright Reiterates Buy Rating on SpyGlass Pharma (SGP) Oct 5, 2026 06:44AM
SpyGlass Pharma (SGP) Reiterated at Buy by Stifel as AVS Acquisition Announced Oct 2, 2026 08:03AM
Raymond James Starts SpyGlass Pharma (SGP) at Outperform Aug 14, 2026 06:06AM


Aug 7, 2026 04:15PM SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59
Jun 15, 2026 08:02AM SpyGlass Pharma names Shannon Treviño as general counsel
May 15, 2026 06:07AM SpyGlass Pharma, Inc. (SGP) Reports Q1 Loss of $0.69
Mar 27, 2026 12:26PM Stifel on SpyGlass Pharma (SGP): complete enrollment indication reinforces approval confidence
Mar 26, 2026 05:19PM SpyGlass Pharma (SGP) Misses Q4 EPS by 572c
Mar 10, 2026 06:45AM H.C. Wainwright Starts SpyGlass Pharma (SGP) at Buy
Mar 3, 2026 06:19AM Leerink Partners Starts SpyGlass Pharma (SGP) at Outperform
Mar 3, 2026 06:07AM Jefferies Starts SpyGlass Pharma (SGP) at Buy
Mar 3, 2026 05:01AM Citi Starts SpyGlass Pharma (SGP) at Buy
Mar 3, 2026 02:15AM Stifel Starts SpyGlass Pharma (SGP) at Buy
Feb 6, 2026 01:49PM SpyGlass Pharma (SGP) resumes trading, up 103%
Jan 29, 2026 03:08PM SpyGlass Pharma (SGP) files for 9.375M share IPO at $15-$17/sh
Jan 16, 2026 03:13PM SpyGlass Pharma (SGP) files for proposed IPO